Journey Clinical is a New York-based healthtech company that operates a collaborative-care platform enabling licensed psychotherapists to offer Ketamine-Assisted Psychotherapy (KAP) inside their own private practices. Its in-house medical team handles patient eligibility, ketamine prescriptions, and ongoing medical monitoring, while therapists deliver the preparation, dosing, and integration sessions. The model expands safe, legal access to psychedelic-assisted care for patients with depression, anxiety, PTSD, and other conditions, and has grown to a network of over 2,500 trained providers.
Myriam Barthes is the co-founder and CEO of Journey Clinical, a New York-based telehealth platform that provides the medical infrastructure for licensed psychotherapists to offer ketamine-assisted psychotherapy. Starting in strategy consulting at EY and later working as an AI impact strategist at SparkBeyond, she launched Journey Clinical in 2020 with Jonathan Sabbagh and has grown it into the largest network of KAP-trained therapists in the United States.